Hubert-Yeargan Advisory Committee
Samuel L. Katz, MD
Duke University Medical Center
Dr. Katz, the Wilburt Cornell Davison Professor and Chairman emeritus of Pediatrics at Duke University, is an honors graduate of Dartmouth College and Harvard Medical School. After medical internship at Beth Israel Hospital he completed Pediatrics residency training at the Massachusetts General Hospital and the Boston Children’s Hospital, followed by a research fellowship in virology and infectious diseases, and then became a staff member at Children’s Hospital working with Nobel Laureate John F. Enders. During his twelve years with Enders, they developed the attenuated measles virus vaccine now used worldwide. Katz’ career has been devoted to infectious disease research focusing principally on vaccine research, development and policy. In addition to his investigations of measles, he has been involved in studies of vaccinia, polio, rubella, influenza, pertussis, haemophilus influenzae b conjugates, HIV and others. He has Chaired the Committee on Infectious Diseases of the American Academy of Pediatrics (Redbook Committee), the Advisory Committee on Immunization Practices (ACIP) of the CDC, the Vaccine Priorities Study of the Institute of Medicine (IOM), and several WHO, CVI and NIH panels. He is a member of many scientific advisory committees and boards including the NIH, FDA, IOM, WHO, St. Jude Children’s Research Hospital and the Hasbro Children’s Foundation. He chaired the Public Policy Council of the Infectious Diseases Society of America (IDSA) and currently co-chairs its National Network for Immunization Information. For 5 years he was co-chair of the Indo-US Vaccine Action Program.
Dr. Katz has received many honors including the Jacobi Award of the AAP and AMA, the Grulee Award of the AAP, the first St. Geme Award of the seven academic Pediatric Societies, the Presidential Medal of Dartmouth College, the Bristol Award and the Society Citation of the IDSA, the Distinguished Physician Award of the Pediatric Infectious Diseases Society, honorary doctorates from Georgetown University and Dartmouth College, and honorary fellowships in many international organizations. He has been president of the American Pediatric Society and of the Association of Medical School Pediatric Department Chairmen, and received the Howland Award of the American Pediatric Society. Since 1982, he has been a member of the Institute of Medicine of the National Academy of Sciences. In 2003 he received the Gold Medal of the Albert Sabin Vaccine Institute and in 2004 Duke University’s Founders’ Medal.
Dr. Katz has participated actively in pediatric educational and research programs throughout the world in at least 15 countries. He currently chairs the Board of the International Vaccine Institute in Seoul, Korea. His published studies include abundant original scientific articles, chapters in textbooks, abstracts, commentaries, editorials and reviews. He is co-editor of a textbook (now in its 11th edition) on pediatric infectious diseases and has given more than 70 named lectures in the U.S. and abroad.
For 22 years, Dr. Katz was Chairman of Duke University's Department of Pediatrics. In addition to mentoring two decades of students and residents, he established an exchange program with Oxford University and provided training for an annual succession of residents from the American University of Beirut. Graduates of his program hold positions at FDA, CDC, NIH, university departments, state health departments, pharmaceutical firms, research institutes and in private practice. Having relinquished the Chairmanship in 1990, his activities continue with vaccines and pediatric AIDS. He participates in the clinical research trials of the NIH, served on their Committee for AIDS Vaccines, devotes time to the care of children with HIV infection, and was a member of the Executive Committee of NIAID’s Pediatric ACTG. His vaccine policy work continues through CDC, IOM, NIH, AAP, FDA, IDSA and WHO committees and consultancies.
TB Trials Consortium and the CDC to study ways to enhance patient recruitment and retention in clinical trials in US public health clinics.